Lataa...
Mutation Profile Assessed by Next-Generation Sequencing (NGS) of Circulating Tumor DNA (ctDNA) in Chinese Lung Adenocarcinoma Patients: Analysis of Real-World Data
BACKGROUND: Genomic testing gives guidance to the treatment options in lung adenocarcinoma patients, but some patients are unable to obtain tissue samples due to lesion location or intolerance. Cell-free circulating tumor DNA (ctDNA) tested in plasma or pleural effusion is an advanced access to solv...
Tallennettuna:
| Julkaisussa: | Biomed Res Int |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8116141/ https://ncbi.nlm.nih.gov/pubmed/33997043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/8817898 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|